Curcumin, a substance in turmeric, has been linked to improved respiratory health in premature infants with inadequate lung function.
Researchers from LA BioMed at the University of California, Los Angeles found that the antioxidant, anti-inflammatory and anti-microbial properties of the spice can help counteract some of the damage done during oxygen therapy.
The next step is to look at incorporating the curcumin compounds into oxygen therapy and ventilation assistance to increase survival rates in premature infants.
Read more at University of California, Los Angeles